ClinicalTrials.Veeva

Menu

Improving Disease Severity

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Active, not recruiting

Conditions

Psoriasis
Alopecia Areata
Polymorphous Light Eruption

Treatments

Other: Lumiton yarn shirt
Other: Lumiton yarn hat
Other: Lumiton yarn sleeve

Study type

Interventional

Funder types

Other

Identifiers

NCT05391178
IRB00084854

Details and patient eligibility

About

Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the most common conditions treated with phototherapy, in which phototherapy is often indicated for extensive disease with contraindications for other systemic treatments. The mechanism of action of phototherapy for the treatment of psoriasis is not completely understood; however, it is known that UVB light induces apoptosis of pathogenic T cells and keratinocytes, which may reduce the overactive immune response and epidermal hyperproliferation. Phototherapy has shown some efficacy for other diseases, such as alopecia areata (AA) and polymorphous light eruption (PMLE). However, phototherapy is not always an accessible treatment option for patients due to cost or lack of time.

Full description

Recent advancements in nanotechnology have led to the development of medical devices (lasers and LED devices) with unique phototherapy properties that emit radiation in the infrared wavelengths, allowing patients to benefit from the effects of phototherapy treatment in a more convenient way. Preclinical studies demonstrated the positive effects of infrared radiation exposure on the skin including, increased collagen synthesis and expression of transforming growth factor-beta1 (TGF-beta1). Other studies suggested possible antimicrobial effects from infrared radiation, with decreased colonization of Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae on the skin after exposure. Compared to other fabric technology, such as Far-Infrared (FIR) fabric technology that reflects body heat, fabric made from Lumiton yarn converts external light in the UV and visible spectrum and emits light in the red and near-infrared spectrum for the body. Lumiton yarn absorbs energy from 350 nm to 600 nm (the light spectrum from UV to visible red light) and emit energy from 600 to 1000 nm (red, near-infrared spectrum). The Lumiton yarn contains red/NIR light-emitting dyes. The effectiveness of the technology is proportional to the intensity of the light, with its peak effectiveness under sunlight.

Enrollment

13 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult participants ≥18 years of age
  • Participants who live in the US,
  • Participants who are diagnosed with mild-to-severe AA, PMLE, or psoriasis
  • Participants have sufficient command of the English language

Exclusion criteria

  • Participants less than the age of 18
  • Participants who do not live in the US
  • Participants who are not diagnosed with mild to severe AA, PMLE, or psoriasis
  • Participants without a sufficient command of the English language
  • Participants with concurrent medical conditions that are at risk of confounding the study outcomes
  • Participants currently using concomitant phototherapy

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

13 participants in 3 patient groups

Psoriasis
Active Comparator group
Description:
Psoriasis participants will be provided sleeves made from the Lumiton yarn to cover their arms. The participants will be instructed to wear the sleeves made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Treatment:
Other: Lumiton yarn sleeve
Alopecia Areata
Active Comparator group
Description:
Alopecia areata participants will be provided a hat made from the Lumiton yarn. The participants will be instructed to wear the hat made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Treatment:
Other: Lumiton yarn hat
Polymorphous Light Eruption
Active Comparator group
Description:
Polymorphous light eruption participants will be provided a shirt made from the Lumiton yarn. The participants will be instructed to wear the shirt made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Treatment:
Other: Lumiton yarn shirt

Trial contacts and locations

1

Loading...

Central trial contact

Irma M Richardson, MHA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems